reference/25521979

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25521979

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	1622
issn	1557-3265 1078-0432
issueIdentifier	5
pageRange	1612-1622
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	1612
bibliographicCitation	Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Clin Cancer Res. 2009 Mar 01;15(5):1612–22. doi: 10.1158/1078-0432.ccr-08-2057. PMID: 19223496.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f6012acc5aa87153fa8f90d8090d257 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77f3c4e90ea2128a160e875e97f77826 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_391481609ee44a0fa2eb55516a95c31a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86f7846960966107f91572abe033ded9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7ca6d74b4ea3679e69cc53f19a8580d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2551a32120be54257275665aaead6b45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_814708cfba68a95a27ccfcb0f13b8b4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_311fd314af5c2fdd16f22c07c1a26810 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba8e8f475794eba283ee50c59680a40a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b42e83e3f32fbe63ae45a1ff4c3de0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57394c4d727e159693af0a38a286d4c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_703a51aef3a648dc2394d4f2a855e634
date	2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19223496 https://doi.org/10.1158/1078-0432.ccr-08-2057
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
discusses	http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0016766 http://id.nlm.nih.gov/mesh/M0441463 http://id.nlm.nih.gov/mesh/M0356369 http://id.nlm.nih.gov/mesh/M0017869 http://id.nlm.nih.gov/mesh/M0469192 http://id.nlm.nih.gov/mesh/M000602394 http://id.nlm.nih.gov/mesh/M0217220 http://id.nlm.nih.gov/mesh/M0469193 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0358615 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0185203 http://id.nlm.nih.gov/mesh/M0328153
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009389Q000188 http://id.nlm.nih.gov/mesh/D011494Q000737 http://id.nlm.nih.gov/mesh/D020533Q000494 http://id.nlm.nih.gov/mesh/D020123Q000031 http://id.nlm.nih.gov/mesh/D011725Q000494 http://id.nlm.nih.gov/mesh/D009374Q000098 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D010793Q000494 http://id.nlm.nih.gov/mesh/D040262Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014018 http://id.nlm.nih.gov/mesh/D007124 http://id.nlm.nih.gov/mesh/D020123Q000493 http://id.nlm.nih.gov/mesh/D002465Q000187 http://id.nlm.nih.gov/mesh/D008279 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D042787Q000378 http://id.nlm.nih.gov/mesh/D020533Q000493 http://id.nlm.nih.gov/mesh/D020123Q000494 http://id.nlm.nih.gov/mesh/D009374Q000188 http://id.nlm.nih.gov/mesh/D011920 http://id.nlm.nih.gov/mesh/D042461Q000378 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D047428Q000493 http://id.nlm.nih.gov/mesh/D000068338 http://id.nlm.nih.gov/mesh/D058570 http://id.nlm.nih.gov/mesh/D011725Q000493 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D009374Q000378 http://id.nlm.nih.gov/mesh/D010793Q000493 http://id.nlm.nih.gov/mesh/D014183 http://id.nlm.nih.gov/mesh/D040262Q000378 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D011494Q000378 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D011914
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4fb3b68e84149f91bcfd0102f95d3731 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22386467 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3a236e0877bf928b9d51ea42ef63147c http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3bc9fee8d7f8d8fe9c4a4defc07ab136 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151194 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151193 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9b7de8e681f4022e1c87b09017acfc60 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248184126 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242749350 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128132375 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129776330

Total number of triples: 102.